Skip to main content
Clinical Trials/NCT01838096
NCT01838096
Unknown
Not Applicable

Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years

Seoul National University Bundang Hospital0 sites92 target enrollmentMarch 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Advanced Hip Disease
Sponsor
Seoul National University Bundang Hospital
Enrollment
92
Primary Endpoint
survival rate of 4th generation ceramic-on-ceramic THA
Last Updated
4 years ago

Overview

Brief Summary

This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty ("THA") in patients younger than 30 years.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
November 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kyung-Hoi Koo

Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • younger than 30 years
  • advanced hip disease

Exclusion Criteria

  • older than 30 years

Outcomes

Primary Outcomes

survival rate of 4th generation ceramic-on-ceramic THA

Time Frame: 5 years

survival rate of 4th generation ceramic-on-ceramic THA end point for best senario ; any reoperation end point for moderate senario ; loosening end point for worst senario ; osteolysis

Similar Trials